InvestorsHub Logo
Followers 2
Posts 164
Boards Moderated 0
Alias Born 01/26/2010

Re: None

Wednesday, 01/15/2014 5:42:19 PM

Wednesday, January 15, 2014 5:42:19 PM

Post# of 64403





FDA Painkiller Restrictions could boost NYLOXIN - Coverage Initiated on NPHC

h
WASHINGTON, (Reuters) - The U.S. Food and Drug Administration recommended tighter restrictions on products that contain hydrocodone, an opioid painkiller present in commonly prescribed, potentially addictive drugs such as Vicodin.

Nyloxin is a non addictive option to opiate based painkillers. It is posed to take advantage of the new restrictions. Marketing Nyloxin as a non addictive painkiller at the same time the FDA restricts opiate based painkiilers could be very beneficial to NPHC shareholders We may see increased interest in the security NPHC.